Literature DB >> 30988564

VEGF Promoter Region 18-bp Insertion-Deletion Polymorphism in Sickle Cell Disease Patients with Microalbuminuria: A Pilot Study.

Dnyanesh B Amle1, Rachana L Patnayak1, Varsha Verma1, Gajendra Kumar Singh1, Vijaylakshmi Jain1, P K Khodiar1, P K Patra2.   

Abstract

PURPOSE: Vascular endothelial growth factor (VEGF) is a potent inducer of micro vascular permeability thus leading to nephropathy. Insertion/deletion (I/D) polymorphism of 18 bp at - 2549 position in VEGF gene causes increased transcription leading to increased production of VEGF. Thus, we aimed to associate I/D polymorphism of the 18 bp fragment at - 2549 position of the promoter region of VEGF gene with sickle cell nephropathy (SCN).
METHODS: This observational analytical case control study included 30 subjects each of SCN, sickle cell disease (SCD) without nephropathy and the control group. The subjects were assessed for various hematological and biochemical parameters. Further, 18 bp I/D polymorphism of VEGF gene in all three study groups was assessed by polymerase chain reaction followed by electrophoresis and compared. RESULT: Though increased frequency of both DD genotype and D allele was found in SCN compared to SCD and control, only frequency of D allele was found to be significantly higher (p = 0.04). D allele posed marginal risk of microalbuminuria in SCD subjects compared to controls (OR = 2.11) as well as to SCD without MA subjects (OR = 1.84).
CONCLUSION: D allele in I/D polymorphism in the promoter region of VEGF gene may be associated with marginal increase in risk of susceptibility to sickle cell nephropathy.

Entities:  

Keywords:  Polymorphism; Sickle cell disease; Sickle cell nephropathy; VEGF

Year:  2018        PMID: 30988564      PMCID: PMC6439237          DOI: 10.1007/s12288-018-1018-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

1.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection.

Authors:  Majid Shahbazi; Anthony A Fryer; Vera Pravica; Iain J Brogan; Helen M Ramsay; Ian V Hutchinson; Paul N Harden
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.

Authors:  Antonio Guasch; Jose Navarrete; Kaleed Nass; Carlos F Zayas
Journal:  J Am Soc Nephrol       Date:  2006-07-12       Impact factor: 10.121

3.  Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy.

Authors:  S Marsh; F M Nakhoul; K Skorecki; A Rubin; B P Miller; R Leibu; N S Levy; A P Levy
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

4.  Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.

Authors:  Monika Buraczynska; Piotr Ksiazek; Iwona Baranowicz-Gaszczyk; Lucyna Jozwiak
Journal:  Nephrol Dial Transplant       Date:  2006-11-22       Impact factor: 5.992

5.  Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.

Authors:  Adam Stevens; Joanne Soden; Paul E Brenchley; Shirley Ralph; David W Ray
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

6.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

7.  Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.

Authors:  A K Gupta; K A Kirchner; R Nicholson; J G Adams; A N Schechter; C T Noguchi; M H Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

8.  Renal abnormalities in patients with sickle cell disease: a single center report from Saudi Arabia.

Authors:  Aamer Aleem
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-03

9.  Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.

Authors:  Bingmei Yang; Deborah F Cross; Martin Ollerenshaw; Beverly A Millward; Andrew G Demaine
Journal:  J Diabetes Complications       Date:  2003 Jan-Feb       Impact factor: 2.852

Review 10.  Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.

Authors:  Martin H Steinberg
Journal:  ScientificWorldJournal       Date:  2008-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.